Meeting of the Advisory Committee, 55984-55985 [2024-14991]

Download as PDF 55984 Federal Register / Vol. 89, No. 130 / Monday, July 8, 2024 / Notices Title of Collection: 30 CFR 250, Subpart J, Pipelines and Pipeline Rightsof-Way (ROW). OMB Control Number: 1014–0016. Form Number: Forms BSEE–0149— Assignment of Federal OCS Pipeline Right-of-Way Grant, and Form BSEE– 0135—Designation of Right-of-Way Operator. Type of Review: Extension of a currently approved collection. Respondents/Affected Public: Potential respondents include Federal OCS oil, gas, and sulfur lessees and/or operators and holders of pipeline rightsof-way. Total Estimated Number of Annual Respondents: Currently there are approximately 550 Federal OCS oil, gas, and sulfur lessees and holders of pipeline rights-of-way. Not all the potential respondents will submit information in any given year, and some may submit multiple times. Total Estimated Number of Annual Responses: 2,802. Estimated Completion Time per Response: Varies from 30 minutes to 107 hours, depending on activity. Total Estimated Number of Annual Burden Hours: 34,206. Respondent’s Obligation: Submissions are mandatory or are required to obtain or retain a benefit. Frequency of Collection: Submissions are generally on occasion. Total Estimated Annual Nonhour Burden Cost: $1,344,916. An agency may not conduct, or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Kirk Malstrom, Chief, Regulations and Standards Branch. [FR Doc. 2024–14856 Filed 7–5–24; 8:45 am] BILLING CODE 4310–VH–P INTERNATIONAL TRADE COMMISSION khammond on DSKJM1Z7X2PROD with NOTICES [Investigation Nos. 701–TA–727 and 731– TA–1695 (Preliminary)] Disposable Aluminum Containers, Pans, Trays, and Lids From China Determinations On the basis of the record 1 developed in the subject investigations, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports of disposable aluminum containers, pans, trays, and lids from China, provided for in statistical reporting number 7615.10.7125 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value (‘‘LTFV’’) and alleged to be subsidized by the Government of China.2 3 Commencement of Final Phase Investigations Pursuant to section 207.18 of the Commission’s rules, the Commission also gives notice of the commencement of the final phase of its investigations. The Commission will issue a final phase notice of scheduling, which will be published in the Federal Register as provided in § 207.21 of the Commission’s rules, upon notice from the U.S. Department of Commerce (‘‘Commerce’’) of affirmative preliminary determinations in the investigations under §§ 703(b) or 733(b) of the Act, or, if the preliminary determinations are negative, upon notice of affirmative final determinations in those investigations under §§ 705(a) or 735(a) of the Act. Parties that filed entries of appearance in the preliminary phase of the investigations need not enter a separate appearance for the final phase of the investigations. Any other party may file an entry of appearance for the final phase of the investigations after publication of the final phase notice of scheduling. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigations. As provided in section 207.20 of the Commission’s rules, the Director of the Office of Investigations will circulate draft questionnaires for the final phase of the investigations to parties to the investigations, placing copies on the Commission’s Electronic Document Information System (EDIS, https:// edis.usitc.gov), for comment. Background On May 16, 2024, the Aluminum Foil Container Manufacturers Association, Lexington, Kentucky, and its individual members Durable Packaging International, Wheeling, Illinois; D&W Fine Pack, LLC, Wood Dale, Illinois; Handi-Foil Corp., Wheeling, Illinois; Penny Plate, LLC, Fishersville, Virginia; Reynolds Consumer Products, LLC, Lake Forest, Illinois; Shah Foil Products, Inc., Piscataway Township, New Jersey; Smart USA, Inc., Bay Shore, New York; and Trinidad/Benham Corp., Denver, Colorado, filed petitions with the Commission and Commerce, alleging that an industry in the United States is materially injured or threatened with material injury by reason of subsidized and LTFV imports of disposable aluminum containers, pans, trays, and lids from China. Accordingly, effective May 16, 2024, the Commission instituted countervailing duty investigation No. 701–TA–727 and antidumping duty investigation No. 731–TA–1695 (Preliminary). Notice of the institution of the Commission’s investigations and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of May 22, 2024 (89 FR 45016). The Commission conducted its conference on June 6, 2024. All persons who requested the opportunity were permitted to participate. The Commission made these determinations pursuant to §§ 703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It completed and filed its determinations in these investigations on July 9, 2024. The views of the Commission are contained in USITC Publication 5523 (July 2024), entitled Disposable Aluminum Containers, Pans, Trays, and Lids from China: Investigation Nos. 701–TA–727 and 731–TA–1695 (Preliminary). By order of the Commission. Issued: July 2, 2024. Lisa Barton, Secretary to the Commission. [FR Doc. 2024–14905 Filed 7–5–24; 8:45 am] BILLING CODE 7020–02–P JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES Meeting of the Advisory Committee 1 The record is defined in § 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). VerDate Sep<11>2014 16:22 Jul 05, 2024 Jkt 262001 FR 49833 and 89 FR 49837 (June 12, 2024). 3 Commissioner Rhonda K. Schmidtlein not participating. PO 00000 2 89 Frm 00072 Fmt 4703 Sfmt 4703 Joint Board for the Enrollment of Actuaries. AGENCY: E:\FR\FM\08JYN1.SGM 08JYN1 55985 Federal Register / Vol. 89, No. 130 / Monday, July 8, 2024 / Notices about the changes, as required by 41 CFR 102–3.150(a). Notice of Federal Advisory Committee meeting; amended. ACTION: Dated: July 3, 2024. Thomas V. Curtin, Jr., Executive Director, Joint Board for the Enrollment of Actuaries. This notice amends the location of the partially closed meeting of the Advisory Committee on Actuarial Examinations previously announced in the Federal Register of June 14, 2024. SUMMARY: [FR Doc. 2024–14991 Filed 7–5–24; 8:45 am] BILLING CODE 4830–01–P July 11, 2024, from 9 a.m. to 5 p.m., and July 12, 2024, from 9:30 a.m. to 3 p.m. DATES: DEPARTMENT OF JUSTICE FOR FURTHER INFORMATION CONTACT: Elizabeth Van Osten, Designated Federal Officer, Advisory Committee on Actuarial Examinations, at (202) 312– 3648 or Elizabeth.jvanosten@irs.gov. As published in the Federal Register of June 14, 2024 (89 FR 50634), the meeting was to be held at the Internal Revenue Service, 1111 Constitution Avenue NW, Washington, DC 20224. However, due to an unexpected building closure precluding an inperson meeting, the meeting will be held by teleconference instead. There are no other changes to the meeting. Because the circumstances necessitating the change to the venue of the meeting are beyond the control of the Joint Board or the Enrollment of Actuaries, it is unable to provide public notification SUPPLEMENTARY INFORMATION: Drug Enforcement Administration [Docket No. DEA–1389] Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to SUMMARY: the issuance of the proposed registration on or before September 6, 2024. Such persons may also file a written request for a hearing on the application on or before September 6, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on May 29, 2024, Curia Missouri Inc., 2460 West Bennett Street, Springfield, Missouri 65807–1229, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance Drug code Gamma Hydroxybutyric Acid ......................................................................................................................................... Amphetamine ................................................................................................................................................................. Lisdexamfetamine .......................................................................................................................................................... Methylphenidate ............................................................................................................................................................. Phenylacetone ............................................................................................................................................................... Tapentadol ..................................................................................................................................................................... The company plans to bulk manufacture the listed controlled substances for internal use intermediates or for sale to its customers. No other activities for these drug codes are authorized for this registration. Marsha L. Ikner, Acting Deputy Assistant Administrator. [FR Doc. 2024–14926 Filed 7–5–24; 8:45 am] BILLING CODE P khammond on DSKJM1Z7X2PROD with NOTICES DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1385] Bulk Manufacturer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma Drug Enforcement Administration, Justice. AGENCY: VerDate Sep<11>2014 16:22 Jul 05, 2024 Jkt 262001 ACTION: Notice of application. S&B Pharma LLC DBA Norac Pharma has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 6, 2024. Such persons may also file a written request for a hearing on the application on or before September 6, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for SUMMARY: PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 2010 1100 1205 1724 8501 9780 Schedule I II II II II II lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. In accordance with 21 CFR 1301.33(a), this is notice that on April 30, 2024, S&B Pharma LLC DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: E:\FR\FM\08JYN1.SGM 08JYN1

Agencies

Joint Board for the Enrollment of Actuaries

[Federal Register Volume 89, Number 130 (Monday, July 8, 2024)]
[Notices]
[Pages 55984-55985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-14991]


=======================================================================
-----------------------------------------------------------------------

JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES


Meeting of the Advisory Committee

AGENCY: Joint Board for the Enrollment of Actuaries.

[[Page 55985]]


ACTION: Notice of Federal Advisory Committee meeting; amended.

-----------------------------------------------------------------------

SUMMARY: This notice amends the location of the partially closed 
meeting of the Advisory Committee on Actuarial Examinations previously 
announced in the Federal Register of June 14, 2024.

DATES: July 11, 2024, from 9 a.m. to 5 p.m., and July 12, 2024, from 
9:30 a.m. to 3 p.m.

FOR FURTHER INFORMATION CONTACT: Elizabeth Van Osten, Designated 
Federal Officer, Advisory Committee on Actuarial Examinations, at (202) 
312-3648 or [email protected].

SUPPLEMENTARY INFORMATION: As published in the Federal Register of June 
14, 2024 (89 FR 50634), the meeting was to be held at the Internal 
Revenue Service, 1111 Constitution Avenue NW, Washington, DC 20224. 
However, due to an unexpected building closure precluding an in-person 
meeting, the meeting will be held by teleconference instead. There are 
no other changes to the meeting. Because the circumstances 
necessitating the change to the venue of the meeting are beyond the 
control of the Joint Board or the Enrollment of Actuaries, it is unable 
to provide public notification about the changes, as required by 41 CFR 
102-3.150(a).

    Dated: July 3, 2024.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the Enrollment of Actuaries.
[FR Doc. 2024-14991 Filed 7-5-24; 8:45 am]
BILLING CODE 4830-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.